Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma – analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIM
Authors:
- Jan-Malte PlackeJan-Malte Placke
- Mona KimmigMona Kimmig
- Klaus GriewankKlaus Griewank
- Rudolf HerbstRudolf Herbst
- Patrick TerheydenPatrick Terheyden
- Jochen UtikalJochen Utikal
- Claudia PföhlerClaudia Pföhler
- Jens UlrichJens Ulrich
- Alexander KreuterAlexander Kreuter
- Peter MohrPeter Mohr
- Ralf GutzmerRalf Gutzmer
- Friedegund MeierFriedegund Meier
Open Access
- 4 September 2023
- journal article
- research article
- Published by Elsevier in EBioMedicine
- Vol. 96, 104774
Abstract
No abstract availableKeywords
Funding Information
- Bristol-Myers Squibb
- University Hospital Essen
- Deutsche Forschungsgemeinschaft (16–1, EN984/15–1, FOR5427 SP4, TR296 P09, TR332 A3)
- Else Kröner-Fresenius-Stiftung
This publication has 33 references indexed in Scilit:
- Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategiesAnnals of Oncology, 2015
- Pembrolizumab versus Ipilimumab in Advanced MelanomaNew England Journal of Medicine, 2015
- PD-L1 Expression as a Predictive Biomarker in Cancer ImmunotherapyMolecular Cancer Therapeutics, 2015
- Nivolumab in Previously Untreated Melanoma withoutBRAFMutationNew England Journal of Medicine, 2015
- Improved Overall Survival in Melanoma with Combined Dabrafenib and TrametinibNew England Journal of Medicine, 2015
- PD‐L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti‐PD‐1/PD‐L1 clinical trialsPigment Cell & Melanoma Research, 2014
- PD-1 blockade induces responses by inhibiting adaptive immune resistanceNature, 2014
- Human Melanoma Metastases Demonstrate Nonstochastic Site-Specific Antigen Heterogeneity That Correlates with T-cell InfiltrationClinical Cancer Research, 2014
- Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic MelanomaCancer Research, 2012
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response CriteriaClinical Cancer Research, 2009